Using an inferior decoy alternative to nudge COVID-19 vaccination.

Publication date: Jan 11, 2025

Optimizing vaccine uptake is a public health challenge that requires the implementation of effective strategies. The asymmetric dominance (or decoy) effect describes the increasing likelihood of selecting an option when a clearly inferior alternative is offered. Therefore, we aimed to test the impact of offering decoy alternatives-less convenient vaccination appointments-on vaccination intentions. Participants aged 18-33 years, residing in England, and initially not intending to get vaccinated, completed three online experiments. Participants were randomly assigned to either a control or an experimental condition in each experiment. The asymmetrically dominated options were: an appointment in two weeks at a distant location (experiment 1); a later time at the participant’s local GP, pharmacy, or community centre (experiment 2); and a later time at a distant location (experiment 3). The primary outcome was vaccination intention, while secondary outcomes included an active interest in reading additional information about the vaccination procedure, perceived difficulty and cognitive effort. Initial analysis revealed no evidence of an asymmetric dominance effect. However, further subgroup analysis, supported by formative research, indicated that ensuring decoy alternatives are clearly perceived as inferior could enhance the effectiveness of this approach for certain individuals.

Open Access PDF

Concepts Keywords
Covid Adolescent
Increasing Adult
Inferior Asymmetric dominance effect
Nudge Behavioural public policy
Vaccine COVID-19
COVID-19
COVID-19 Vaccines
COVID-19 Vaccines
Decision making
Decoy effect
England
Female
Humans
Intention
Male
Nudge
SARS-CoV-2
Vaccination
Vaccination hesitancy
Young Adult

Semantics

Type Source Name
disease MESH COVID-19
disease MESH infection
disease MESH death
disease IDO susceptibility
disease MESH influenza
disease MESH educational attainment
disease MESH morbidity
drug DRUGBANK Coenzyme M
disease IDO process
disease IDO intervention
disease IDO site
drug DRUGBANK Aspartame
drug DRUGBANK L-Phenylalanine
drug DRUGBANK Guanosine
drug DRUGBANK Polyethylene glycol
pathway REACTOME Reproduction

Original Article

(Visited 2 times, 1 visits today)